LIFECORE BIOMEDICAL, INC. (LFCR) 8-K Summary

This 8-K reports the results of the 2025 Annual Meeting of Stockholders held on October 29, 2025.

Key Voting Outcomes:

• Director Elections: All nine director nominees were elected to serve until the 2026 Annual Meeting.
  • Seven directors were elected by holders of Common Stock and Series A Preferred Stock voting together.
  • Two directors were elected solely by Series A Preferred Stock holders.
• Auditor Ratification: Stockholders ratified the appointment of KPMG LLP as the independent registered public a